Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportClinical Neurosciences (including neuro-oncology)

Evaluation of longitudinal changes in reference region uptake and extracerebral signal of [18F]MK-6240 PET

Jessie Fang Lu Fu, Cristina Lois, Justin Sanchez, J. Alex Becker, Zoe Rubinstein, Emma Thibault, Andrew Salvatore, Hasan Sari, Michelle Farrell, Marc Normandin, Nicolas Guehl, Georges El Fakhri, Keith Johnson and Julie Price
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2285;
Jessie Fang Lu Fu
1Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristina Lois
2Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justin Sanchez
3Massachusetts General Hospital - Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Alex Becker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zoe Rubinstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma Thibault
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Salvatore
4MGH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hasan Sari
5Siemens Healthcare AG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle Farrell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Normandin
6Gordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Guehl
7Harvard Medical School - MA General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georges El Fakhri
8Massachusetts General Hospital, Harvard Medical School
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith Johnson
9Harvard MGH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Price
10Massachusetts General Hospital, Martinos Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

2285

Introduction: [18F]MK-6240 PET is used for detecting tau deposition in Alzheimer's disease (AD). Off-target binding of [18F]MK-62401 in the meningeal/extracerebral area can impact the quantification of reference and target region uptake2. A previous study suggested an annual increase of 0.01-0.15 in target region standardized uptake value (SUV) ratios (SUVR90-110) in cognitively normal (CN) and AD subjects3. However, reports on longitudinal stability of reference region and extracerebral uptake have been limited. In a cross-sectional dataset, we previously showed that lower uptake in white-matter (WM)-rich reference regions allows for larger dynamic range of target uptake in low-binders. Here, we extended the previous study by evaluating the longitudinal change of reference region and extracerebral uptake across the AD spectrum.

Methods: Baseline [18F]MK-6240 PET imaging (0-120 min, 180±10 MBq, GE Discovery-MI) was performed in 24 CN (age 68±12), 6 mild cognitive impairment (MCI) and 2 AD subjects (age 70±11)4. Follow-up scans at 6.1±0.5 months and 13.3±0.9 months (1-year) were performed in 25 (20 CN, 5 AD/MCI) and 16 (11 CN, 5 AD/MCI) subjects, respectively. Candidate reference regions included cerebellar gray matter (CerGM), CerGM eroded by 3mm (CerGM3mm), inferior CerGM, cerebral WM and pons. Uptake kinetics were evaluated using SUV90-110 for reference regions, and using SUV90-110 and SUVR90-110 (reference region: CerGM3mm) for extracerebral uptake. Longitudinal change (?SUV) was calculated as (SUV90-110,follow-up-SUV90-110,baseline) and was compared between reference regions and diagnostic groups. The proportion of subjects with high extracerebral SUVR90-110 was examined with histogram analysis. Baseline amyloid-b burden was estimated in frontal, lateral temporo-parietal and retrosplenial (FLR) regions using 11C-PiB distribution volume ratio (DVR >1.2, PiB-positive). Partial volume correction (PVC) was not performed.

Results: Baseline SUV90-110 (0.16–1.01 g/mL) was higher in CerGM-based regions than WM-rich regions. WM SUV90-110 was ~1.5-fold higher in AD/MCI than CN subjects. At group-level, no reference region showed significant ?SUV at either follow-up (Table.1, Fig.1A). ?SUV was similar between diagnostic groups and was lowest in pons (6-month:0.02±0.05, 1-year: -0.002±0.07) and highest in CerGM-based regions (6-month: 0.04±0.07, 1-year: 0.04±0.13, Table.1), although no significant difference was observed across reference regions. ?SUV in reference regions indicated high inter-subject (standard deviation: 0.05–0.13) and intra-subject (range: -0.24–0.26) variability at both follow-ups. Baseline extracerebral SUV90-110 (0.54–1.12 g/mL) was similar across groups. At group-level, extracerebral ?SUV (6-month: 0.01±0.12, 1-year: 0.0002±0.16) was similar across diagnostic groups with similar magnitude but larger variability than the reference regions. Histogram analysis yielded a baseline extracerebral SUVR90-110 threshold of 1.39 that assigned 50% of subjects to a high extracerebral uptake group (Fig.1B-C). At follow-ups, the group assignments remained for all subjects except for 1 MCI subject.

Conclusions: Based on these analyses, the WM reference region showed higher SUV90-110  in AD/MCI than CN subjects possibly due to spill-in signal, and is not optimal for cross-sectional nor longitudinal studies involving high-binders without PVC. The reference region ?SUV was similar in magnitude and variability as annual increases reported for target uptake in CN subjects3, although ?SUV90-110 was not significant over 1-year. The pons may be preferred for longitudinal studies due to its lower magnitude and variability of ?SUV. The extracerebral uptake was stable over 1 year at group-level, but exhibited high variability independent of the diagnostic groups. This work is our first step to evaluate factors that impact the sensitivity for detecting robust biological changes in target uptake. Our next efforts will examine how these factors propagate to target region uptake.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of longitudinal changes in reference region uptake and extracerebral signal of [18F]MK-6240 PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Evaluation of longitudinal changes in reference region uptake and extracerebral signal of [18F]MK-6240 PET
Jessie Fang Lu Fu, Cristina Lois, Justin Sanchez, J. Alex Becker, Zoe Rubinstein, Emma Thibault, Andrew Salvatore, Hasan Sari, Michelle Farrell, Marc Normandin, Nicolas Guehl, Georges El Fakhri, Keith Johnson, Julie Price
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2285;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluation of longitudinal changes in reference region uptake and extracerebral signal of [18F]MK-6240 PET
Jessie Fang Lu Fu, Cristina Lois, Justin Sanchez, J. Alex Becker, Zoe Rubinstein, Emma Thibault, Andrew Salvatore, Hasan Sari, Michelle Farrell, Marc Normandin, Nicolas Guehl, Georges El Fakhri, Keith Johnson, Julie Price
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2285;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Quantification of brain glucose metabolism by 18F-FDG PET/MR with image-derived input function in ischemic cerebrovascular disease
  • Preliminary impact of serial hybrid [18F]FET PET/MR perfusion on the management of patients with malignant brain tumors at a single United States institution.
  • Presynaptic Dopaminergic function and brain metabolism in the Nigrostriatal and Mesocortical Systems in Early onset-Parkinson’s Disease
Show more Clinical Neurosciences (including neuro-oncology)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire